Detalhe da pesquisa
1.
Immunotoxin targeting EpCAM effectively inhibits peritoneal tumor growth in experimental models of mucinous peritoneal surface malignancies.
Int J Cancer
; 133(6): 1497-506, 2013 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23494569
2.
Intraperitoneal Paclitaxel Is a Safe and Effective Therapeutic Strategy for Treating Mucinous Appendiceal Adenocarcinoma.
Cancer Res
; 83(19): 3184-3191, 2023 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433032
3.
Antitumor activity of intraperitoneal paclitaxel in orthotopic patient-derived xenograft models of mucinous appendiceal adenocarcinoma.
bioRxiv
; 2023 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36993681
4.
Anti-Angiogenic Treatment in Pseudomyxoma Peritonei-Still a Strong Preclinical Rationale.
Cancers (Basel)
; 13(11)2021 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34198773
5.
Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei.
J Immunother Cancer
; 9(10)2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34711663
6.
MOC31PE immunotoxin - targeting peritoneal metastasis from epithelial ovarian cancer.
Oncotarget
; 8(37): 61800-61809, 2017 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28977905
7.
Use of non-invasive imaging to monitor response to aflibercept treatment in murine models of colorectal cancer liver metastases.
Clin Exp Metastasis
; 34(1): 51-62, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27812769
8.
hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma.
Cell Death Discov
; 2: 16081, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-28028438
9.
Individual tumor volume responses to short-course oxaliplatin-containing induction chemotherapy in locally advanced rectal cancer - Targeting the tumor for radiation sensitivity?
Radiother Oncol
; 119(3): 505-11, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26968754
10.
Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors.
Oncotarget
; 7(15): 19997-20015, 2016 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26918352
11.
Targeted Cancer Therapy with a Novel Anti-CD37 Beta-Particle Emitting Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma.
PLoS One
; 10(6): e0128816, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26066655